» Articles » PMID: 25130959

Validating Laboratory Results in a National Observational Cohort Study Without Field Centers: the Reasons for Geographic and Racial Differences in Stroke Cohort

Overview
Journal Clin Biochem
Specialty Biochemistry
Date 2014 Aug 19
PMID 25130959
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The REasons for Geographic and Racial Differences in Stroke (REGARDS) study is a prospective cohort of 30,239 Americans in the contiguous United States; the first of this scale to use home visits to obtain, process, and ship biologic samples to a core laboratory. Pre-analytical factors resulting from this study design may affect the results of some laboratory assays. We investigated the impact of REGARDS processing on a variety of analytes.

Design And Methods: In REGARDS, blood samples were processed in the field by technicians who were trained on standardized methods for phlebotomy and sample processing. Field processing included centrifugation using varying non-uniform equipment and shipping overnight on ice to the University of Vermont, where samples were re-centrifuged for 30,000 ×g-minutes and stored at -80 °C. We assessed the effects of REGARDS sample handling by processing split samples from 20 volunteers using either ideal procedures or simulated REGARDS procedures. Assays for 19 analytes for potential study in REGARDS were then run on both samples and results compared.

Results: Spearman correlation coefficients for analytes measured in ideal versus REGARDS processed samples ranged from 0.11 to 1.0. Thirteen of 19 analytes were highly correlated (>0.75), but platelet proteins were more variable.

Conclusions: Simulation of non-optimal field processing and shipment to a central laboratory showed high variability in analytes released by platelets. The majority of other analytes produced valid results, but platelet contamination in REGARDS samples makes measurement of platelet proteins unadvisable in these samples. Future analytes considered by REGARDS or similar studies should undergo similar pilot testing.

Citing Articles

Targeted Metabolomics in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Ament Z, Kijpaisalratana N, Bhave V, Couch C, Garcia Guarniz A, Patki A Sci Data. 2025; 12(1):395.

PMID: 40050322 PMC: 11885657. DOI: 10.1038/s41597-025-04746-x.


Measuring Hemoglobin A1C with Frozen Packed Cell and Frozen Whole Blood Samples in an Epidemiologic Study: The Reasons for Geographic and Racial Differences in Stroke Study.

Kamin Mukaz D, Tison S, Long D, Carson A, Hunt K, Judd S J Clin Lab Anal. 2025; 39(4):e25121.

PMID: 39921333 PMC: 11848213. DOI: 10.1002/jcla.25121.


Kidney Function, Cognitive Impairment, and Trajectories: A Longitudinal Biracial Study.

Cheung K, Arce Renteria M, Callas P, Kurella Tamura M, Gutierrez O, Cushman M J Gen Intern Med. 2025; .

PMID: 39843671 DOI: 10.1007/s11606-025-09366-0.


Plasma Biomarkers of Kidney Health and Mortality in Diabetes and Chronic Kidney Disease in the REGARDS Study.

Chen T, Estrella M, Katz R, Sarnak M, Grams M, Cushman M Clin J Am Soc Nephrol. 2024; 19(12):1585-1593.

PMID: 39652331 PMC: 11637710. DOI: 10.2215/CJN.0000000000000544.


The association of leptin and incident hypertension in the reasons for geographic and racial differences in stroke (REGARDS) cohort.

Sherman S, Stoutenburg E, Long D, Juraschek S, Cushman M, Howard V J Hum Hypertens. 2024; 38(12):836-843.

PMID: 39354067 DOI: 10.1038/s41371-024-00963-w.


References
1.
Liu L, Choi H, Bernardo A, Bergeron A, Nolasco L, Ruan C . Platelet-derived VWF-cleaving metalloprotease ADAMTS-13. J Thromb Haemost. 2005; 3(11):2536-44. DOI: 10.1111/j.1538-7836.2005.01561.x. View

2.
Booth N, Simpson A, Croll A, Bennett B, MacGREGOR I . Plasminogen activator inhibitor (PAI-1) in plasma and platelets. Br J Haematol. 1988; 70(3):327-33. DOI: 10.1111/j.1365-2141.1988.tb02490.x. View

3.
Holland N, Smith M, Eskenazi B, Bastaki M . Biological sample collection and processing for molecular epidemiological studies. Mutat Res. 2003; 543(3):217-34. DOI: 10.1016/s1383-5742(02)00090-x. View

4.
Pai J, Curhan G, Cannuscio C, Rifai N, Ridker P, Rimm E . Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection. Clin Chem. 2002; 48(10):1781-4. View

5.
Kaplan R, Ho G, Xue X, Rajpathak S, Cushman M, Rohan T . Within-individual stability of obesity-related biomarkers among women. Cancer Epidemiol Biomarkers Prev. 2007; 16(6):1291-3. DOI: 10.1158/1055-9965.EPI-06-1089. View